Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000899243-22-012463

Options or other derivatives

  • Director acquired 36,211 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lee Frank D. Director 2022-03-24 Grant or award · Stock Option (Right to Buy) +22,140 22,140 D
Lee Frank D. Director 2022-03-24 Grant or award · Stock Option (Right to Buy) +14,071 14,071 D
Loading xslF345X03/doc4.xml…